Regulus Therapeutics
RGLS
#7242
Rank
C$0.80 B
Marketcap
C$11.61
Share price
0.00%
Change (1 day)
461.36%
Change (1 year)

Regulus Therapeutics (RGLS) - Cash on Hand

Cash on Hand as of March 2025 : C$92.99 Million

According to Regulus Therapeutics's latest financial reports the company has C$92.99 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Regulus Therapeutics - Cash on Hand chart (from 2011 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31C$0.10 B244.95%
2023-12-31C$31.52 M-40.68%
2022-12-31C$53.13 M-30.95%
2021-12-31C$76.95 M94.14%
2020-12-31C$39.63 M-11.05%
2019-12-31C$44.56 M134.77%
2018-12-31C$18.98 M-74.87%
2017-12-31C$75.52 M-26.16%
2016-12-31C$0.10 B-35.36%
2015-12-31C$0.15 B-14.65%
2014-12-31C$0.18 B52.75%
2013-12-31C$0.12 B24.41%
2012-12-31C$97.55 M151.42%
2011-12-31C$38.8 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Sanofi
SNY
C$9.12 B 9,716.33%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
C$6.09 B 6,451.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$14.91 B 15,941.49%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$10.91 B 11,641.22%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
C$6.48 B 6,875.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
C$42.13 M-54.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$4.28 B 4,503.51%๐Ÿ‡บ๐Ÿ‡ธ USA